Kiichi Sugimoto

Kiichi Sugimoto

Auto-generated profile, based on publicly available information

Kiichi Sugimoto

Department of Coloproctological Surgery Juntendo University Faculty of Medicine Tokyo Japan

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2024 in Annals of Coloproctology
Verified
Journal Article
Open access
PDF file
MKMasaya Kawai
Masaya Kawai
KSKazuhiro Sakamoto
Kazuhiro Sakamoto
KHKumpei Honjo
Kumpei Honjo
YOYu Okazawa
Yu Okazawa
RTRina Takahashi
Rina Takahashi
YTYuichi Tomiki
Yuichi Tomiki
Purpose: A consensus has been reached regarding diverting stoma (DS) construction in rectal cancer surgery to avoid reoperation related to anastomotic leakage. However, the incidence of stoma-related complications (SRCs) remains high. In this study, we examined the perioperative outcomes of DS construction in patients who underwent sphincter-preserving surgery for rectal cancer.Methods: We included 400 participants who underwent radical sphincter-preserving surgery for rectal cancer between 2005 and 2017. These participants were divided into the DS (+) and DS (–) groups, and the outcomes, including postoperative complications, were compared.Results: The incidence of ileus was higher in the DS (+) group than in the DS (–) group (P<0.01); however, no patients in the DS (+) group showed grade 3 anastomotic leakage. Furthermore, early SRCs were observed in 33 patients (21.6%) and bowel obstruction-related stoma outlet syndrome occurred in 19 patients (12.4%). There was no significant intergroup difference in the incidence of grade 3b postoperative complications. However, the most common reason for reoperation was different in the 2 groups: anastomotic leakage in 91.7% of patients with grade 3b postoperative complications in the DS (–) group, and SRCs in 85.7% of patients with grade 3b postoperative complications in the DS (+) group.Conclusion: Patients with DS showed higher incidence rates of overall postoperative complications, severe postoperative complications (grade 3), and bowel obstruction, including stoma outlet syndrome, than patients without DS. Therefore, it is important to construct an appropriate DS to avoid SRCs and to be more selective in assigning patients for DS construction.

11 December 2015 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
RTRina Takahashi
Rina Takahashi
RIRyosuke Ichikawa
Ryosuke Ichikawa
SISingo Ito
Singo Ito
KMKosuke Mizukoshi
Kosuke Mizukoshi
SIShun Ishiyama
Shun Ishiyama
KSKazuhiro Sakamoto
Kazuhiro Sakamoto
This case involved an 80-year-old man who was seen for melena. Further testing revealed a tubular adenocarcinoma 50 mm in size in the rectum. In addition, an anal fistula was noted behind the anus along with induration. A biopsy of tissue from the external (secondary) opening of the fistula also revealed adenocarcinoma. Nodules suspected of being metastases were noted in both lung fields. The patient was diagnosed with rectal cancer, a cancer arising from an anal fistula, and a metastatic pulmonary tumor, and neoadjuvant chemotherapy was begun. A laparoscopic abdominoperineal resection was performed 34 days after 6 cycles of mFOLFOX-6 therapy. Based on pathology, the rectal cancer was diagnosed as moderately differentiated adenocarcinoma, and this adenocarcinoma had lymph node metastasis (yp T3N2aM1b). There was no communication between the rectal lesion and the anal fistula, and a moderately differentiated tubular adenocarcinoma resembling the rectal lesion was noted in the anal fistula. Immunohistochemical staining indicated that both the rectal lesion and anal fistula were cytokeratin 7 (CK7) (−) and cytokeratin 20 (CK20) (+), and the patient’s condition was diagnosed as implantation of rectal cancer in an anal fistula. In instances where an anal fistula develops in colon cancer, cancer implantation in that fistula must also be taken into account, and further testing should be performed prior to surgery.

10 July 2018 in Journal of Gastrointestinal Cancer
Verified
Journal Article
Closed access
PDF file
HKHisaki Kato
Hisaki Kato
SMShinya Munakata
Shinya Munakata
KSKazuhiro Sakamoto
Kazuhiro Sakamoto
KSKiichi Sugimoto
Kiichi Sugimoto
RYRiku Yamamoto
Riku Yamamoto
KSKoichi Sato
Koichi Sato

6 November 2012 in Surgery Today
Verified
Journal Article
Closed access
PDF file
KSKiichi Sugimoto
Kiichi Sugimoto
KSKoichi Sato
Koichi Sato
HMHiroshi Maekawa
Hiroshi Maekawa
MSMutsumi Sakurada
Mutsumi Sakurada
HOHajime Orita
Hajime Orita
KSKazuhiro Sakamoto
Kazuhiro Sakamoto

27 October 2017 in Journal of the Anus, Rectum and Colon
Verified
Journal Article
Open access
PDF file
SMShinya Munakata
Shinya Munakata
SIShingo Ito
Shingo Ito
KSKiichi Sugimoto
Kiichi Sugimoto
YKYutaka Kojima
Yutaka Kojima
MGMichitoshi Goto
Michitoshi Goto
KSKazuhiro Sakamoto
Kazuhiro Sakamoto
Objectives: Temporary ileostomy is used to decrease morbidity from anastomotic leakages (ALs). However, ileostomies are associated with complications (i.e., stoma-related complications; SRCs), ileus due to stenosis, dehydration, and the need for a second operation. Here we retrospectively evaluated the impact of SRCs on the treatment of rectal cancer. Methods: We identified 180 consecutive patients who underwent curative resection for rectal cancer at Juntendo University Hospital between January 2006 and December 2014. We divided the patients into groups with and without defunctioning stoma (DS), and we compared the patient age and gender, tumor location, approach (laparotomy/laparoscopy), surgical procedure, distance of the tumor from the margin of the anus, T factor, stage, duration of postoperative hospital stay, and postoperative complications between these groups. Univariate and multivariate analyses were performed to determine the risk factors for postoperative hospital stay. Results: The symptomatic leakage rate in the DS group (n = 92) was not significantly different from that of the non-DS group (n = 88; p = 0.29). However, Grade ≥ 4 AL occurred significantly less frequently in the DS group (0%) than in the non-DS group (5.7%; p = 0.02). SRCs occurred in 14 DS-group patients (15.2%). The multivariate analysis demonstrated that both AL (odds ratio [OR] 9.24; confidence interval [CI] 4.91-19.4) and SRC (OR 1.84; CI 1.03-3.54) were independently predictive of short-term outcomes. Conclusions: The benefit of a DS is balanced against the risk of leakage and SRCs at rectal resection. Surgeons should focus on not only the consequences of AL, but also SRC risk.

2 September 2019 in Translational Cancer Research
Verified
Journal Article
Open access
KSKiichi Sugimoto
Kiichi Sugimoto
KSKazuhiro Sakamoto
Kazuhiro Sakamoto
MKMasaya Kawai
Masaya Kawai
SKShingo Kawano
Shingo Kawano
SMShinya Munakata
Shinya Munakata
YTYuichi Tomiki
Yuichi Tomiki
Background: Few previous studies have investigated the relationship between serum oxidative stress and the status of patients with colorectal cancer. Our aim in the current study was to investigate the significance of serum oxidative stress as a prognostic marker in these patients. Methods: The subjects were 53 patients who underwent curative resection of high-risk stage II or stage III colorectal cancer. The correlation of serum oxidative stress (Reactive Oxygen Metabolites Test: d-ROMs Test) with recurrence-free survival was examined. Results: There were no significant differences in d-ROMs between the recurrence and non-recurrence groups at four time points (0M: before the start of postoperative adjuvant chemotherapy; and 1M: 1 month; 3M: 3 months; and 6M: 6 months after the start of postoperative adjuvant chemotherapy). Only the 3M/0M d-ROMs (the value at 3M relative to the value at OM) was increased compared with the other time points in the recurrence group, as well as with all time points in the non-recurrence group. In univariate analysis, there were significant differences in recurrence-free survival with respect to N classification (P=0.004) and 3M/0M d-ROMs (P=0.002). In multivariate analysis, both N classification and serum oxidative stress were found to be significant independent prognostic factors (P=0.02, HR=4.49; P=0.02, H R=5.61, respectively). Conclusions: The results of this study demonstrate the prognostic value of serum oxidative stress in colorectal cancer.